Tag Archives: U.S.

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »

Most U.S. patients not using online medical portals

(Reuters Health) – Most people in the U.S. with health insurance don’t use the patient portals that are increasingly provided by doctors for online communication, a new study suggests. In a nationally representative survey, researchers found that nearly two-thirds of insured participants had not used an online medical portal in the past year. Disparities among… Read More »

Widespread, occasional use of antibiotics in U.S. linked with resistance

The increasing prevalence of antibiotic resistance in the U.S. appears more closely linked to their occasional use by many people than to their repeated use among smaller numbers of people, according to a large new study from Harvard T.H. Chan School of Public Health. The study also found that antibiotic use varies across the nation,… Read More »